A detailed history of Bank Of America Corp transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 76 shares of ANEB stock, worth $95. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 65 16.92%
Holding current value
$95
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.77 - $3.08 $19 - $33
11 Added 16.92%
76 $0
Q2 2024

Aug 14, 2024

BUY
$1.9 - $3.12 $123 - $202
65 New
65 $0
Q4 2023

Feb 14, 2024

BUY
$1.71 - $3.17 $6 - $12
4 New
4 $0

Others Institutions Holding ANEB

About Anebulo Pharmaceuticals, Inc.


  • Ticker ANEB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,633,200
  • Market Cap $32M
  • Description
  • Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...
More about ANEB
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.